Case Report

Published on 12 Dec 2022

Case report: Complete response of a bladder cancer patient with multiple hepatic and pelvic metastases treated by nab-paclitaxel combined with sintilimab

in Genitourinary Oncology

Zhu-lei Tao
Wei Wu
Lin-chun Liang
Jin-feng Pan
Jian-zhou Cao
Xiao-long Jia
Li Fang
Qi Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.1020793

1,880 views
3 citations

Clinical Trial

Published on 12 Dec 2022

Preference-based versus randomized controlled trial in prostate cancer survivors: Comparison of recruitment, adherence, attrition, and clinical outcomes

in Genitourinary Oncology

Shabbir M. H. Alibhai
Efthymios Papadopoulos
Sara Durbano
George Tomlinson
Daniel Santa Mina
Paul Ritvo
Catherine M. Sabiston
Andrew G. Matthew
James Chiarotto
Souraya Sidani

Frontiers in Oncology

doi 10.3389/fonc.2022.1033229

2,660 views
3 citations

Original Research

Published on 09 Dec 2022

Prognosis and pain dissection of novel signatures in kidney renal clear cell carcinoma based on fatty acid metabolism-related genes

in Genitourinary Oncology

Ruifeng Ding
Huawei Wei
Xin Jiang
Liangtian Wei
Mengqiu Deng
Hongbin Yuan

Frontiers in Oncology

doi 10.3389/fonc.2022.1094657

3,183 views
3 citations

Original Research

Published on 08 Dec 2022

Impact of the time of surgical delay on survival in patients with muscle-invasive bladder cancer

in Genitourinary Oncology

Shuaishuai Li
Rui Chen
Ashok Raj
Ning Xue
Fangzheng Zhao
Xihao Shen
Yunpeng Peng
Haitao Zhu

Frontiers in Oncology

doi 10.3389/fonc.2022.1001843

1,460 views
2 citations

Original Research

Published on 08 Dec 2022

Complexity in radiological morphology predicts worse prognosis and is associated with an increase in proteasome component levels in clear cell renal cell carcinoma

in Genitourinary Oncology

Kohei Kobatake
Kenichiro Ikeda
Jun Teishima
Yohei Sekino
Takashi Babasaki
Yuki Kohada
Ryo Tasaka
Kenshiro Takemoto
Takafumi Fukushima
Shunsuke Miyamoto

Frontiers in Oncology

doi 10.3389/fonc.2022.1039383

2,328 views
1 citation

Original Research

Published on 06 Dec 2022

Nomograms predict survival benefits of radical prostatectomy and chemotherapy for prostate cancer with bone metastases: A SEER‐based study

in Genitourinary Oncology

Donglin Sun
Ao Lin
Zhun Sun
Shuqi Yang
Yuexin Sun
Anning Chen
Guojun Qian
Zhonghua Ji
Li Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1020898

2,202 views
1 citation

Original Research

Published on 06 Dec 2022

Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerations

in Genitourinary Oncology

Luigi Nocera
Lara F. Stolzenbach
Claudia Collà Ruvolo
Mike Wenzel
Christoph Wurnschimmel
Zhe Tian
Giorgio Gandaglia
Nicola Fossati
Vincenzo Mirone
Felix K. H. Chun

Frontiers in Oncology

doi 10.3389/fonc.2022.990851

1,253 views
1 citation

Original Research

Published on 05 Dec 2022

Biparametric MRI-based radiomics classifiers for the detection of prostate cancer in patients with PSA serum levels of 4∼10 ng/mL

in Genitourinary Oncology

Yangbai Lu
Binfei Li
Hongxing Huang
Qu Leng
Qiang Wang
Rui Zhong
Yaqiang Huang
Canyong Li
Runqiang Yuan
Yongxin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1020317

2,401 views
10 citations

Opinion

Published on 05 Dec 2022

Gleason 6 prostate cancer: That which cannot be named

in Genitourinary Oncology

Harry B. Burke

Frontiers in Oncology

doi 10.3389/fonc.2022.1073580

24,386 views
1 citation

Original Research

Published on 05 Dec 2022

Evaluation of the role of local therapy in patients with cN1M0 prostate cancer: A population-based study from the SEER database

in Genitourinary Oncology

Feng Qi
Wenbo Xu
Lu Li
Xiao Li
Zicheng Xu

Frontiers in Oncology

doi 10.3389/fonc.2022.1050317

1,932 views

Original Research

Published on 05 Dec 2022

CT-based deep learning radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer

in Genitourinary Oncology

Weitian Chen
Mancheng Gong
Dongsheng Zhou
Lijie Zhang
Jie Kong
Feng Jiang
Shengxing Feng
Runqiang Yuan

Frontiers in Oncology

doi 10.3389/fonc.2022.1019749

2,409 views
14 citations

Original Research

Published on 05 Dec 2022

Multi-omics profiles refine L-dopa decarboxylase (DDC) as a reliable biomarker for prognosis and immune microenvironment of clear cell renal cell carcinoma

in Genitourinary Oncology

Kun Chang
Jiaqi Su
Chuanyu Li
Aihetaimujiang Anwaier
Wangrui Liu
Wenhao Xu
Yuanyuan Qu
Hailiang Zhang
Dingwei Ye

Frontiers in Oncology

doi 10.3389/fonc.2022.1079446

2,847 views
3 citations

Case Report

Published on 02 Dec 2022

Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients

in Genitourinary Oncology

Andrea Boutros
Lara Vera
Federico Gatto
Giuseppe Fornarini
Elisa Zanardi

Frontiers in Oncology

doi 10.3389/fonc.2022.1048526

2,335 views
1 citation

Systematic Review

Published on 02 Dec 2022

Immune-based treatment re-challenge in renal cell carcinoma: A systematic review and meta-analysis

in Genitourinary Oncology

Maria Papathanassiou
Ioannis Tamposis
Kalliopi K. Exarchou-Kouveli
Panagiota I. Kontou
Anna Tzortzi de Paz
Lampros Mitrakas
Maria Samara
Pantelis G. Bagos
Vassilios Tzortzis
Panagiotis J. Vlachostergios

Frontiers in Oncology

doi 10.3389/fonc.2022.996553

3,377 views
3 citations

Case Report

Published on 02 Dec 2022

Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah’s witness: A case report

in Genitourinary Oncology

Tony Zibo Zhuang
Lara Harik
Seth Force
Agreen Hadadi
Mehmet Asim Bilen
Jacqueline T. Brown
Bradley C. Carthon
Jamie Goldman
Omer Kucuk
Viraj A. Master

Frontiers in Oncology

doi 10.3389/fonc.2022.949400

2,028 views

Case Report

Published on 01 Dec 2022

Case report: Paratesticular dedifferentiated liposarcoma with poor prognosis

in Genitourinary Oncology

Hirotaka Suto
Yumiko Inui
Atsuo Okamura

Frontiers in Oncology

doi 10.3389/fonc.2022.1085794

1,360 views
3 citations

Navigation group

Articles

Case report: Complete response of a bladder cancer patient with multiple hepatic and pelvic metastases treated by nab-paclitaxel combined with sintilimab

Preference-based versus randomized controlled trial in prostate cancer survivors: Comparison of recruitment, adherence, attrition, and clinical outcomes

Prognosis and pain dissection of novel signatures in kidney renal clear cell carcinoma based on fatty acid metabolism-related genes

Impact of the time of surgical delay on survival in patients with muscle-invasive bladder cancer

Complexity in radiological morphology predicts worse prognosis and is associated with an increase in proteasome component levels in clear cell renal cell carcinoma

Nomograms predict survival benefits of radical prostatectomy and chemotherapy for prostate cancer with bone metastases: A SEER‐based study

Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerations

Biparametric MRI-based radiomics classifiers for the detection of prostate cancer in patients with PSA serum levels of 4∼10 ng/mL

Gleason 6 prostate cancer: That which cannot be named

Evaluation of the role of local therapy in patients with cN1M0 prostate cancer: A population-based study from the SEER database

CT-based deep learning radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer

Multi-omics profiles refine L-dopa decarboxylase (DDC) as a reliable biomarker for prognosis and immune microenvironment of clear cell renal cell carcinoma

Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients

Immune-based treatment re-challenge in renal cell carcinoma: A systematic review and meta-analysis

Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah’s witness: A case report

Case report: Paratesticular dedifferentiated liposarcoma with poor prognosis